Trials / Completed
CompletedNCT01808872
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 569 (actual)
- Sponsor
- Radiometer Medical ApS · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The AQT90 FLEX B-type Natriuretic Peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) Tests are in vitro diagnostic assays intended as an aid in the diagnosis and assessment of the severity of heart failure in point-of-care and laboratory settings. The purpose of the study is to establish the clinical performance of the AQT90 FLEX BNP and NT-proBNP assays for both whole blood and plasma in the intended use population.
Conditions
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-04-01
- Completion
- 2014-05-01
- First posted
- 2013-03-11
- Last updated
- 2014-05-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01808872. Inclusion in this directory is not an endorsement.